[Skip to content]

Mid Cheshire Hospitals - NHS Foundation Trust
Departments and services How To Find Us
Advanced
Search our Site
.

Thousands Of Patients To Benefit From Eye Care Centre Extension

Eye Care Centre Extension
An impression of the Eye Care Centre extension

26 May 2016

Work has started on a hospital extension that will see more patients being able to access eye care services in Mid Cheshire.

The project, a joint venture between Mid Cheshire Hospitals NHS Foundation Trust (MCHFT) and Novartis Pharmaceuticals UK Ltd, will see the Eye Care Centre at Crewe’s Leighton Hospital extended and further specialist staff recruited.

Over recent years the Centre has seen an increase in demand and currently serves more than 50,000 patients a year.  

Due for completion in August, the two-storey extension and remodelling will allow the service to see more patients and, with the extra space, to improve patient experience.

Stephen Eaton, Divisional General Manager for Surgery and Cancer at MCHFT, said: “It has been reported nationally that eye services are facing increased demand due to an ageing population that require long-term care.

“The redesign of the Eye Care Centre is just one of the things that we, along with Novartis, are doing to ensure we can keep up with this demand and ensure that patients with serious eye conditions continue to access high quality services.”

Hugh O’Dowd, Country President, United Kingdom and Ireland and General Manager of Novartis, added: “This partnership is part of our ongoing commitment at Novartis to working with the NHS to understand and address the challenges facing eye care services across the UK.

“By working closely with Leighton Hospital we hope to develop a redesigned Eye Care Centre that delivers greater accessibility and outcomes for patients, increases capacity and provides more efficient use of resources.”

Leighton Hospital’s Eye Care Centre provides general and specialty Ophthalmology clinics that cover a wide range of eye diseases and visual problems.

Services will continue to run as normal during the development work.